Last reviewed · How we verify

NCT03866733

Continuous Erector Spinea Block Versus Intravenous Analgesia in Coronary Bypass Surgery

Completed NA Last updated 15 January 2021
What this trial tests

NA trial testing continous erector spinea block in Erector Spinea Block in Open Heart Surgery in 60 participants. Completed in 10 December 2020.

Timeline
18 March 2019
Primary endpoint
30 September 2020
10 December 2020

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date18 March 2019
Primary completion30 September 2020
Estimated completion10 December 2020
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 65, any sex, with Erector Spinea Block in Open Heart Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adequate postoperative pain relief in patients in cardiac surgery is very essential. multimodal techniques for perioperative pain management post cardiac surgery include intravenous patient controlled analgesia, thoracic epidural and paravertebral blockade. Analgesia through thoracic epidural is the gold standard technique for post-sternotomy pain control but it has serious complications. ESP block is an easy technique compared to paravertebral block and less hazardous than thoracic epidural. Hence, this study will compare continuous bilateral erector spinae block guided by ultrasound with intravenous analgesia which is the standard method for pain management in cardiac surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03866733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing